access+affordability

A woman who lost her legs after cancer treatment wants to "come home" - but faces being moved 35 miles away.

Americans are having to choose between paying their mortgage and paying for insulin.

How Germany sets drug prices and identifying lessons for the United States.

To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.

The intergovernmental regional initiatives of collaboration around access to medicines policy are here to stay.

UK's NICE has rejected a number of drugs from coverage recently based on cost-effectiveness criteria.

Insulin is not an optional medication for diabetics. Despite little change in production costs, the price of insulin has continued to rise.

About 3,400 pharmacies in Lebanon are suffering from the drop in prices of pharmaceutical drugs, facing the risk of shutting down in the years to come if they can't secure enough revenues.

Hit hard by the opioid crisis, West Virginia is now also contending with a child welfare crisis.

More than half a million Kentuckians have diabetes and many of them depend on insulin every day just to stay alive.

Sometimes, the approval of a new generic drug offers more hype than hope.

At a recent healthcare conference, the CEO of a major hospital corporation mentioned the fact that the healthcare industry was the number 1 culprit for causing personal bankruptcies in the US - but it was ok because their profits are better than ever.

New bill (Senate bill 69) passed into law maybe a relief for diabetes patients.

Sharon Lim has spent $6,000 of her own money to access to a one-month supply of crizotinib.

The real issue is rising patient out-of-pocket costs owing to insufficient benefit design.